Spexis AG (XSWX:SPEX) Other Stockholders Equity : CHF-0.42 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Spexis AG Other Stockholders Equity?

Spexis AG's Other Stockholders Equity for the quarter that ended in Dec. 2023 was CHF-0.42 Mil.

Spexis AG's quarterly Other Stockholders Equity declined from Dec. 2022 (CHF1.00 Mil) to Jun. 2023 (CHF0.57 Mil) and declined from Jun. 2023 (CHF0.57 Mil) to Dec. 2023 (CHF-0.42 Mil).

Spexis AG's annual Other Stockholders Equity increased from Dec. 2021 (CHF0.70 Mil) to Dec. 2022 (CHF1.00 Mil) but then declined from Dec. 2022 (CHF1.00 Mil) to Dec. 2023 (CHF-0.42 Mil).

Spexis AG Other Stockholders Equity Historical Data

The historical data trend for Spexis AG's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spexis AG Other Stockholders Equity Chart

Spexis AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

8.61

1.15

0.70

1.00

-0.42

Spexis AG Semi-Annual Data
	Dec13	Dec14	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Stockholders Equity	Get a 7-Day Free Trial													0.70	1.49	1.00	0.57	-0.42

Spexis AG Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Spexis AG Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Spexis AG's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Spexis AG (XSWX:SPEX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spexis AG (XSWX:SPEX) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

SPEXz:UK

Address

Hegenheimermattweg 125, Allschwil, CHE, CH-4123

Website

https://www.polyphor.com

Spexis AG is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of antibiotics and other specialty pharma products for severe or life-threatening diseases. The company's lead product, murepavadin, is in Phase III development against Pseudomonas aeruginosa - recognized as a critical priority 1 pathogen by World Health Organization. It has one operating segment focusing on the research and development and prospective commercialization of respiratory therapeutics addressing high unmet medical needs.

Spexis AG (XSWX:SPEX) Headlines

No Headlines